![Partial-breast radiotherapy after breast conservation surgery for patients with early breast cancer (UK IMPORT LOW trial): 5-year results from a multicentre, randomised, controlled, phase 3, non-inferiority trial - ScienceDirect Partial-breast radiotherapy after breast conservation surgery for patients with early breast cancer (UK IMPORT LOW trial): 5-year results from a multicentre, randomised, controlled, phase 3, non-inferiority trial - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0140673617311455-gr2.gif)
Partial-breast radiotherapy after breast conservation surgery for patients with early breast cancer (UK IMPORT LOW trial): 5-year results from a multicentre, randomised, controlled, phase 3, non-inferiority trial - ScienceDirect
![Design characteristics, risk of bias, and reporting of randomised controlled trials supporting approvals of cancer drugs by European Medicines Agency, 2014-16: cross sectional analysis | The BMJ Design characteristics, risk of bias, and reporting of randomised controlled trials supporting approvals of cancer drugs by European Medicines Agency, 2014-16: cross sectional analysis | The BMJ](https://cf-images.eu-west-1.prod.boltdns.net/v1/static/2696240571001/ac318747-58bb-4923-a788-d1c43f720ca7/242b264c-0dd9-450e-9857-45666cf48fce/1280x720/match/image.jpg)
Design characteristics, risk of bias, and reporting of randomised controlled trials supporting approvals of cancer drugs by European Medicines Agency, 2014-16: cross sectional analysis | The BMJ
![PDF) Partial-breast radiotherapy after breast conservation surgery for patients with early breast cancer (UK IMPORT LOW trial): 5-year results from a multicentre, randomised, controlled, phase 3, non-inferiority trial PDF) Partial-breast radiotherapy after breast conservation surgery for patients with early breast cancer (UK IMPORT LOW trial): 5-year results from a multicentre, randomised, controlled, phase 3, non-inferiority trial](https://i1.rgstatic.net/publication/318883302_Partial-breast_radiotherapy_after_breast_conservation_surgery_for_patients_with_early_breast_cancer_UK_IMPORT_LOW_trial_5-year_results_from_a_multicentre_randomised_controlled_phase_3_non-inferiority_/links/59833667a6fdcc6d8be0c787/largepreview.png)
PDF) Partial-breast radiotherapy after breast conservation surgery for patients with early breast cancer (UK IMPORT LOW trial): 5-year results from a multicentre, randomised, controlled, phase 3, non-inferiority trial
![Trial by Media (aka An American Daughter) [Import]: Amazon.ca: Christine Lahti, Tom Skerritt, Jay Thomas, Mark Feuerstein, Stanley Anderson, Blake ... Trial by Media (aka An American Daughter) [Import]: Amazon.ca: Christine Lahti, Tom Skerritt, Jay Thomas, Mark Feuerstein, Stanley Anderson, Blake ...](https://m.media-amazon.com/images/I/61dCVVM3gSL._AC_UF894,1000_QL80_.jpg)
Trial by Media (aka An American Daughter) [Import]: Amazon.ca: Christine Lahti, Tom Skerritt, Jay Thomas, Mark Feuerstein, Stanley Anderson, Blake ...
![Dose-escalated simultaneous integrated boost radiotherapy in early breast cancer (IMPORT HIGH): a multicentre, phase 3, non-inferiority, open-label, randomised controlled trial - ScienceDirect Dose-escalated simultaneous integrated boost radiotherapy in early breast cancer (IMPORT HIGH): a multicentre, phase 3, non-inferiority, open-label, randomised controlled trial - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0140673623006190-gr2.jpg)
Dose-escalated simultaneous integrated boost radiotherapy in early breast cancer (IMPORT HIGH): a multicentre, phase 3, non-inferiority, open-label, randomised controlled trial - ScienceDirect
![Journal of Clinical Oncology on X: "Patient-reported outcomes from the IMPORT LOW Trial of whole- or partial-breast RT https://t.co/FFexrqckl3 #radonc #bcsm @ICR_CTSU https://t.co/disj27Cav5" / X Journal of Clinical Oncology on X: "Patient-reported outcomes from the IMPORT LOW Trial of whole- or partial-breast RT https://t.co/FFexrqckl3 #radonc #bcsm @ICR_CTSU https://t.co/disj27Cav5" / X](https://pbs.twimg.com/media/DuULe0XX4AEZpk3.jpg)
Journal of Clinical Oncology on X: "Patient-reported outcomes from the IMPORT LOW Trial of whole- or partial-breast RT https://t.co/FFexrqckl3 #radonc #bcsm @ICR_CTSU https://t.co/disj27Cav5" / X
![Dose-escalated simultaneous integrated boost radiotherapy in early breast cancer (IMPORT HIGH): a multicentre, phase 3, non-inferiority, open-label, randomised controlled trial - ScienceDirect Dose-escalated simultaneous integrated boost radiotherapy in early breast cancer (IMPORT HIGH): a multicentre, phase 3, non-inferiority, open-label, randomised controlled trial - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0140673623006190-gr1.jpg)
Dose-escalated simultaneous integrated boost radiotherapy in early breast cancer (IMPORT HIGH): a multicentre, phase 3, non-inferiority, open-label, randomised controlled trial - ScienceDirect
![Comparison of adverse events in partial- or whole breast radiotherapy: investigation of cosmesis, toxicities and quality of life in a meta-analysis of randomized trials | Radiation Oncology | Full Text Comparison of adverse events in partial- or whole breast radiotherapy: investigation of cosmesis, toxicities and quality of life in a meta-analysis of randomized trials | Radiation Oncology | Full Text](https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs13014-023-02365-7/MediaObjects/13014_2023_2365_Fig5_HTML.png)
Comparison of adverse events in partial- or whole breast radiotherapy: investigation of cosmesis, toxicities and quality of life in a meta-analysis of randomized trials | Radiation Oncology | Full Text
![Partial-breast radiotherapy after breast conservation surgery for patients with early breast cancer (UK IMPORT LOW trial): 5-year results from a multicentre, randomised, controlled, phase 3, non-inferiority trial.,The Lancet - X-MOL Partial-breast radiotherapy after breast conservation surgery for patients with early breast cancer (UK IMPORT LOW trial): 5-year results from a multicentre, randomised, controlled, phase 3, non-inferiority trial.,The Lancet - X-MOL](https://xpic.x-mol.com/20170811%2F10.1016_S0140-6736%2817%2931145-5.jpg)